logo

GENI

Genius Sports·NYSE
--
--(--)
--
--(--)
1.02 / 10
Underperform

Fundamental analysis rates GENI as Underperform with a 1.02/10 score. Key metrics like ROE (-17%) and annualized ROE are negative, cash‑flow coverage is low, and valuation gaps (Asset‑MV, Revenue‑MV) are unfavorable, indicating weak financial health.

Fundamental(1.02)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value-0.30
Score2/3
Weight8.37%
1M Return-1.72%
Annualized return on equity (%)
Value-17.21
Score2/3
Weight8.76%
1M Return-1.96%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score3/3
Weight-11.65%
1M Return2.00%
Profit-MV
Value0.68
Score1/3
Weight20.22%
1M Return-5.18%
Net income-Revenue
Value-0.04
Score1/3
Weight12.28%
1M Return-2.39%
Net cash flow from operating activities / Total liabilities (%)
Value0.21
Score0/3
Weight26.40%
1M Return-6.15%
Interest coverage ratio (EBIT / Interest expense) (%)
Value34.91
Score2/3
Weight13.37%
1M Return-2.87%
EBIT / Total operating revenue (%)
Value-17.04
Score3/3
Weight-8.43%
1M Return1.66%
ROE (%)
Value-17.21
Score2/3
Weight8.76%
1M Return-1.96%
Asset-MV
Value-0.48
Score0/3
Weight21.93%
1M Return-4.36%
Is GENI undervalued or overvalued?
  • GENI scores 1.02/10 on fundamentals and holds a Premium valuation at present. Backed by its -17.21% ROE, -16.67% net margin, -10.47 P/E ratio, 1.61 P/B ratio, and -62.96% earnings growth, these metrics solidify its Underperform investment rating.